Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center
Status:
Completed
Trial end date:
2021-02-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if a single dose of sublingual sufentanil given
15-30 minutes prior to wake up is efficacious at reducing recovery room time.